(2026). Recurrent local and systemic hypersensitivity reactions after switching back from subcutaneous to intravenous vedolizumab in ulcerative colitis: A case presentation. Gastroenterology Report.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Recurrent Local and Systemic Hypersensitivity Reactions After Switching Back from Subcutaneous to Intravenous Vedolizumab in Ulcerative Colitis: A Case Presentation."
Gastroenterology Report 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Recurrent Local and Systemic Hypersensitivity Reactions After Switching Back from Subcutaneous to Intravenous Vedolizumab in Ulcerative Colitis: A Case Presentation."
Gastroenterology Report, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.